Home Compare AZN.L vs EXPN.L
Stock Comparison · Close comparison

AstraZeneca vs Experian: Which Stock Looks Stronger in 2026?

The structural profiles are close, with AstraZeneca carrying a narrow edge on stability. The remaining gap is narrow enough that the comparison remains open to different readings. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the STOXX 600 universe, making them directly comparable.

Updated 2026-08-16

The overall separation remains limited, with no one area creating a decisive distance.

Trajectory Similarity
0.61
Moderately similar
Peer-set rank: #11
within AstraZeneca PLC's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The strongest overlap appears in capital structure and operating margin level.

Similarity drivers
capital structureoperating margin level
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
AZN.L
AstraZeneca PLC
53
Peer-Score
Signal qualityHigh
Peer basis: STOXX 600
vs
EXPN.L
Experian plc
52
Peer-Score
Signal qualityMedium
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: AZN.L vs EXPN.L Profitability 41 35 Stability 58 49 Valuation 54 59 Growth 65 68 AZN.L EXPN.L
Gap Ranking
#1 Stability +9
#2 Profitability +6
#3 Valuation +5
#4 Growth +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AZN.L and EXPN.L Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AZN.LEXPN.L Relative valuation Structural strength

The setup is mixed: neither company clearly combines the stronger profile with the more supportive price setup.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Both rank well on stability, but AstraZeneca PLC still sits higher.
Stability — Dominant Gap
AZN.L
58
EXPN.L
49
Gap+9in favour of AZN.L

The stability gap is visible, with the stronger side looking materially steadier through time.

What keeps the gap from being one-sided

Experian plc still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

The lead is visible, but the profile still looks more expectation-driven than a fully settled winner.

Explore full peer positioning in AssetNext

Break down the AZN.L vs EXPN.L comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other close comparisons

Explore how AZN.L and EXPN.L each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.